Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Relaxin has antifibrotic effects on the hepatic stellate cells (HSCs) responsible for collagen deposition in
cirrhosis
. The expression of relaxin receptors
LGR7
and LGR8 in HSCs and liver disease was examined. Activated and quiescent HSCs expressed
LGR7
, whereas only activated HSCs expressed LGR8. Relaxin, relaxin-3, or InsL3 treatment increased cAMP, suggesting activation of both receptors. LGR8 and
LGR7
were present in cirrhotic rat liver, but were undetectable in normal liver. In conclusion, both
LGR7
and LGR8 are expressed in activated HSCs and cirrhotic liver, suggesting that relaxin, InsL3, or relaxin-3 may be useful in the treatment of hepatic fibrosis.
...
PMID:Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue. 1595 5
The polypeptide hormone relaxin has antifibrotic effects on a number of tissues, including the liver. Central to the progression of hepatic fibrosis is the transdifferentiation of hepatic stellate cells (HSC) from a quiescent state to an activated, myofibroblastic phenotype that secretes fibrillar collagen. Relaxin inhibits markers of HSC activation, but relaxin receptor expression in the liver is unclear. The purpose of this study was to determine the expression of the relaxin receptors
LGR7
and LGR8 in activated HSC. Production of cAMP was induced by treatment of HSC with relaxin, or the relaxin-related peptides InsL3 or relaxin-3, selective activators of LGR8 and
LGR7
, respectively. Quiescent HSC expressed low levels of
LGR7
but not LGR8. During progression to the activated phenotype, expression of both receptors increased markedly. Immunocytochemistry confirmed the presence of both receptors in activated HSC. In normal rat liver,
LGR7
, but not LGR8, was expressed at low levels. In cirrhotic liver, expression of both receptors significantly increased. Neither receptor was detectable in normal liver by immunohistochemistry, but both
LGR7
and LGR8 were readily detectable in
cirrhosis
. These results were confirmed in human cirrhotic tissue, with the additional finding of occasional perisinusoidal
LGR7
immunoreactivity in non-cirrhotic tissue. In conclusion, the expression of
LGR7
and LGR8 is increased with activation of HSC in culture.
Cirrhosis
also caused increased expression of both receptors. Therefore, agents that stimulate LGR8 and
LGR7
may be therapeutically useful to limit the activation of hepatic stellate cells in liver injury.
...
PMID:Relaxin receptors in hepatic stellate cells and cirrhotic liver. 1721 75